Pastan I - Search Results

1

Biodistribution and catabolism of Ga-67-labeled anti-Tac dsFv fragment.

Wu C, Jagoda E, Brechbiel M, Webber KO, Pastan I, Gansow O, Eckelman WC. Wu C, et al. Among authors: pastan i. Bioconjug Chem. 1997 May-Jun;8(3):365-9. doi: 10.1021/bc970032k. Bioconjug Chem. 1997. PMID: 9177842

2

Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts.

Choi CW, Lang L, Lee JT, Webber KO, Yoo TM, Chang HK, Le N, Jagoda E, Paik CH, Pastan I, et al. Choi CW, et al. Among authors: pastan i. Cancer Res. 1995 Nov 15;55(22):5323-9. Cancer Res. 1995. PMID: 7585595

3

Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: comparison with its single-chain analog.

Webber KO, Reiter Y, Brinkmann U, Kreitman R, Pastan I. Webber KO, et al. Among authors: pastan i. Mol Immunol. 1995 Mar;32(4):249-58. doi: 10.1016/0161-5890(94)00150-y. Mol Immunol. 1995. PMID: 7723770

4

Rapid and specific uptake of anti-Tac disulfide-stabilized Fv by interleukin-2 receptor-bearing tumors.

Webber KO, Kreitman RJ, Pastan I. Webber KO, et al. Among authors: pastan i. Cancer Res. 1995 Jan 15;55(2):318-23. Cancer Res. 1995. PMID: 7812965

5

L-lysine effectively blocks renal uptake of 125I- or 99mTc-labeled anti-Tac disulfide-stabilized Fv fragment.

Kobayashi H, Yoo TM, Kim IS, Kim MK, Le N, Webber KO, Pastan I, Paik CH, Eckelman WC, Carrasquillo JA. Kobayashi H, et al. Among authors: pastan i. Cancer Res. 1996 Aug 15;56(16):3788-95. Cancer Res. 1996. PMID: 8706025

6

Technetium-99m labeling and biodistribution of anti-TAC disulfide-stabilized Fv fragment.

Yoo TM, Chang HK, Choi CW, Webber KO, Le N, Kim IS, Eckelman WC, Pastan I, Carrasquillo JA, Paik CH. Yoo TM, et al. Among authors: pastan i. J Nucl Med. 1997 Feb;38(2):294-300. J Nucl Med. 1997. PMID: 9025758 Free article.

7

Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.

Kobayashi H, Yoo TM, Drumm D, Kim MK, Sun BF, Le N, Webber KO, Pastan I, Waldmann TA, Paik CH, Carrasquillo JA. Kobayashi H, et al. Among authors: pastan i. Cancer Res. 1997 May 15;57(10):1955-61. Cancer Res. 1997. PMID: 9157991

8

Factors influencing the in vivo pharmacokinetics of peptides and antibody fragments: the pharmacokinetics of two PET-labeled low molecular weight proteins.

Lang L, Jagoda E, Wu C, Brechbiel MW, Gansow OA, Pastan I, Paik CH, Carrasquillo JA, Eckelman WC. Lang L, et al. Among authors: pastan i. Q J Nucl Med. 1997 Jun;41(2):53-61. Q J Nucl Med. 1997. PMID: 9203844

9

Aminosyn II effectively blocks renal uptake of 18F-labeled anti-tac disulfide-stabilized Fv.

Carrasquillo JA, Lang L, Whatley M, Herscovitch P, Wang QC, Pastan I, Eckelman WC. Carrasquillo JA, et al. Among authors: pastan i. Cancer Res. 1998 Jun 15;58(12):2612-7. Cancer Res. 1998. PMID: 9635587

10

Mutations of two lysine residues in the CDR loops of a recombinant immunotoxin that reduce its sensitivity to chemical derivatization.

Benhar I, Brinkmann U, Webber KO, Pastan I. Benhar I, et al. Among authors: pastan i. Bioconjug Chem. 1994 Jul-Aug;5(4):321-6. doi: 10.1021/bc00028a007. Bioconjug Chem. 1994. PMID: 7948099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,282 results

Search Page

Filters